Eaton Vance Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-525,590
| Closed | -$96.6M | – | 2893 |
|
|
2021
Q2 | $96.6M | Buy |
525,590
+1,619
| +0.3% | +$278K | 0.13% | 163 |
|
|
2021
Q1 | $80.1M | Buy |
523,971
+1,053
| +0.2% | +$163K | 0.12% | 177 |
|
|
2020
Q4 | $81.7M | Sell |
522,918
-21,057
| -4% | -$2.71M | 0.13% | 164 |
|
|
2020
Q3 | $62.2M | Sell |
543,975
-78,207
| -13% | -$8.44M | 0.11% | 173 |
|
|
2020
Q2 | $69.8M | Buy |
622,182
+11,013
| +2% | +$1.17M | 0.14% | 154 |
|
|
2020
Q1 | $54.9M | Buy |
611,169
+358
| +0.1% | +$35.1K | 0.13% | 148 |
|
|
2019
Q4 | $66.1M | Buy |
610,811
+56
| +0% | +$5.99K | 0.13% | 163 |
|
|
2019
Q3 | $59.8M | Sell |
610,755
-31,993
| -5% | -$3.61M | 0.13% | 163 |
|
|
2019
Q2 | $84.2M | Buy |
642,748
+62,297
| +11% | +$8.03M | 0.18% | 122 |
|
|
2019
Q1 | $78.5M | Sell |
580,451
-8,713
| -1% | -$1.08M | 0.18% | 130 |
|
|
2018
Q4 | $57.4M | Sell |
589,164
-506,377
| -46% | -$59.9M | 0.15% | 146 |
|
|
2018
Q3 | $152M | Sell |
1,095,541
-78,124
| -7% | -$9.8M | 0.34% | 88 |
|
|
2018
Q2 | $146M | Sell |
1,173,665
-1,128,531
| -49% | -$132M | 0.35% | 83 |
|
|
2018
Q1 | $257M | Buy |
2,302,196
+1,203,600
| +110% | +$144M | 0.32% | 90 |
|
|
2017
Q4 | $131M | Buy |
1,098,596
+169,542
| +18% | +$20.6M | 0.32% | 88 |
|
|
2017
Q3 | $130M | Buy |
929,054
+91,913
| +11% | +$12.5M | 0.34% | 88 |
|
|
2017
Q2 | $102M | Sell |
837,141
-488,132
| -37% | -$56.8M | 0.27% | 105 |
|
|
2017
Q1 | $161M | Buy |
1,325,273
+555,689
| +72% | +$71.6M | 0.43% | 67 |
|
|
2016
Q4 | $94.2M | Buy |
769,584
+338,722
| +79% | +$41.4M | 0.27% | 105 |
|
|
2016
Q3 | $52.8M | Sell |
430,862
-213,016
| -33% | -$27.4M | 0.15% | 144 |
|
|
2016
Q2 | $75.2M | Buy |
643,878
+398,784
| +163% | +$56.6M | 0.22% | 112 |
|
|
2016
Q1 | $34.1M | Buy |
245,094
+27,835
| +13% | +$4.09M | 0.1% | 164 |
|
|
2015
Q4 | $41.4M | Buy |
217,259
+5,294
| +2% | +$925K | 0.12% | 149 |
|
|
2015
Q3 | $33.1M | Buy |
211,965
+39,181
| +23% | +$7.15M | 0.1% | 170 |
|
|
2015
Q2 | $31.2M | Buy |
172,784
+20,562
| +14% | +$3.55M | 0.1% | 171 |
|
|
2015
Q1 | $26.4M | Buy |
152,222
+49,995
| +49% | +$9.05M | 0.08% | 189 |
|
|
2014
Q4 | $18.9M | Buy |
102,227
+29,890
| +41% | +$5.54M | 0.06% | 239 |
|
|
2014
Q3 | $12M | Buy |
72,337
+36,932
| +104% | +$6.07M | 0.04% | 286 |
|
|
2014
Q2 | $5.53M | Buy |
35,405
+14,005
| +65% | +$2.21M | 0.02% | 374 |
|
|
2014
Q1 | $3.25M | Buy |
21,400
+5
| +0% | +$795 | 0.01% | 451 |
|
|
2013
Q4 | $2.84M | Hold |
21,395
| – | – | 0.01% | 470 |
|
|
2013
Q3 | $2.48M | Buy |
21,395
+2
| +0% | +$219 | 0.01% | 464 |
|
|
2013
Q2 | $1.97M | Buy |
+21,393
| New | +$2.06M | 0.01% | 498 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM